go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

AstraZeneca Pharmaceuticals (Ireland) Ltd
College Park House, 20 Nassau Street, Dublin 2,
Telephone: +353 1 609 7100
Fax: +353 1 679 6650
Medical Information e-mail: Irelandinfo@astrazeneca.com
Patient Information Leaflet last updated on medicines.ie: 22/12/2011
PIL Crestor 5 mg, 10 mg, 20 mg and 40 mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 22/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 08/10/2010 and displayed until 22/12/2011
Reasons for adding or updating:
  • Addition of manufacturer
Updated on 15/06/2010 and displayed until 08/10/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 25/05/2010 and displayed until 15/06/2010
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 16/04/2009 and displayed until 25/05/2010
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to MA holder contact details
Updated on 07/08/2008 and displayed until 16/04/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 02/07/2008 and displayed until 07/08/2008
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 20/03/2008 and displayed until 02/07/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to improve clarity and readability
  • Change to date of revision
Updated on 06/09/2007 and displayed until 20/03/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
Updated on 19/02/2007 and displayed until 06/09/2007
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 08/05/2006 and displayed until 19/02/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 06/12/2005 and displayed until 08/05/2006
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Rosuvastatin Calcium